Computer-Aided Diagnosis Global Market Report 2025

The computer-aided diagnosis market size has grown strongly in recent years. It will grow from $0.94 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to increasing clinician awareness of CAD benefits, expanding government initiatives promoting digital health, greater integration of CAD with imaging modalities, heightened focus on personalized and precision medicine, and rising healthcare spending.

The computer-aided diagnosis market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth projected for the forecast period is driven by the increasing adoption of AI and machine learning in healthcare, the rising prevalence of chronic diseases needing early diagnosis, growing demand for faster and more accurate diagnostic tools, expanding investment in healthcare IT infrastructure, and the rising geriatric population with greater diagnostic requirements. Key trends during this period include advancements in artificial intelligence and deep learning algorithms, development of advanced imaging techniques, technological progress in cloud computing for data storage and processing, creation of real-time diagnostic and decision support tools, and the emergence of multi-modal imaging analysis platforms.

The increasing prevalence of breast cancer is anticipated to drive growth in the computer-aided diagnosis (CAD) market moving forward. Breast cancer is a malignant growth of abnormal cells that typically begins in the milk ducts or lobules of breast tissue. Higher obesity rates contribute to increased breast cancer risk because excess fat elevates estrogen levels, which can promote tumor development. CAD supports breast cancer detection by improving the accuracy and efficiency of identifying tumors in medical images, assisting radiologists in making earlier and more reliable diagnoses. For example, in September 2022, the National Center for Biotechnology Information, a US government agency, projected that by 2040, the annual number of new breast cancer cases will increase by over 40%, reaching nearly 3 million. Thus, the rising incidence of breast cancer is fueling growth in the computer-aided diagnosis market.

Leading companies in the computer-aided diagnosis market are concentrating on developing technologically advanced products, such as AI-powered computer-aided detection (CADe) software, to improve diagnostic accuracy and streamline workflow efficiency. AI-powered CADe software utilizes artificial intelligence and machine learning to automatically detect and highlight potential abnormalities or diseases in medical images, aiding clinicians in making early and precise diagnoses. For example, in March 2025, Align Technology Inc., a US-based manufacturing firm, launched Align X-ray Insights, an AI-driven CADe solution. This software performs automated analysis of 2D dental radiographs to assist clinicians in diagnosing dental and oral conditions, while supporting standardized assessments, optimized clinical workflows, and greater patient engagement. It enhances dental practices by automating image analysis, standardizing diagnostics, improving workflow efficiency, and facilitating better patient communication and treatment acceptance.

In March 2022, Microsoft Corporation, a US-based IT company, acquired Nuance Communications Inc. for an undisclosed sum. Through this acquisition, Microsoft intends to bolster its leadership in cloud computing and AI-powered healthcare by incorporating Nuance’s advanced conversational AI and ambient intelligence to improve clinical workflows and broaden its market presence. Nuance Communications Inc., also based in the US, is a software company offering integrated computer-aided diagnosis (CAD) solutions within its radiology platforms to enhance workflow efficiency and diagnostic precision.

Major players in the computer-aided diagnosis market are Hitachi Ltd, International Business Machines Corporation (IBM), Median Technologies, Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Nano-X Imaging Ltd, Hologic Inc., Agfa-Gevaert NV, ESAOTE S.p.A., Samsung Medison, Merge Healthcare Inc., Canon Medical Systems Corporation, iCAD Inc., THERAPIXEL S.A.S., Riverain Technologies LLC, Zebra Medical Vision Ltd, CureMetrix Inc., EDDA Technology Inc.

North America was the largest region in the computer-aided diagnosis market in 2024. The regions covered in computer-aided diagnosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the computer-aided diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Computer-aided diagnosis (CAD) involves the use of computer systems and algorithms to support healthcare professionals in interpreting medical images and other diagnostic information. CAD enhances the accuracy, consistency, and efficiency of detecting abnormalities, such as tumors or lesions, by marking suspicious areas for further examination.

The imaging modalities used in computer-aided diagnosis include mammography, nuclear imaging, ultrasound imaging, magnetic resonance imaging, and others. Mammography utilizes low-dose X-rays specifically aimed at imaging breast tissue to detect abnormalities like tumors or calcifications. These technologies are employed in diagnosing a range of conditions, including breast cancer, lung cancer, prostate cancer, Alzheimer’s disease, diabetic retinopathy, and more. The main end users are hospitals, clinics, medical diagnostic centers, and other healthcare facilities.

The computer-aided diagnosis market research report is one of a series of new reports that provides computer-aided diagnosis market statistics, including the computer-aided diagnosis industry's global market size, regional shares, competitors with the computer-aided diagnosis market share, detailed computer-aided diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the computer-aided diagnosis market. This computer-aided diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The computer-aided diagnosis market consists of revenues earned by entities by providing services such as image analysis and interpretation, second opinion support, and risk assessment and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The computer-aided diagnosis market also includes sales of CAD for bone fractures, CAD for pathology, and CAD for diabetic retinopathy. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.